Screener
Opus Genetics IRD Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
| Assets | As of / March 31,2026 / (Unaudited) | As of / December 31,2025 |
|---|---|---|
| Accounts receivable | 1,731 | 1,995 |
| Contract assets and unbilled receivables (Note 10) | 984 | 1,170 |
| Prepaids and other current assets | 3,927 | 1,788 |
| Total current assets | 66,601 | 50,044 |
| Property and equipment, net | 186 | 199 |
| Total assets | $66,787 | $50,243 |
| Liabilities, convertible preferred stock and stockholders’ (deficit) equity | ||
| Current liabilities: |
Item 1. Financial Statements
FAQ
- What is Opus Genetics's total current assets?
- Opus Genetics (IRD) reported total current assets of $66.6M in Q1 2026.
- How has Opus Genetics's total current assets changed year-over-year?
- Opus Genetics's total current assets increased by 39.0% year-over-year, from $47.93M to $66.6M.
- What is the long-term trend for Opus Genetics's total current assets?
- Over 5 years (2020 to 2025), Opus Genetics's total current assets has grown at a 23.1% compound annual growth rate (CAGR), from $17.67M to $50.04M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Opus Genetics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude